Pan malarial antigens: Difference between revisions
From MalariaETC
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:<span style="position: absolute; clip: rect(1px 1px 1px 1px); clip: rect(1px, 1px, 1px, 1px);">{{FULLPAGENAME}}</span>}} | {{DISPLAYTITLE:<span style="position: absolute; clip: rect(1px 1px 1px 1px); clip: rect(1px, 1px, 1px, 1px);">{{FULLPAGENAME}}</span>}} | ||
---- | ---- | ||
<span style="font-size:90%" | <span style="font-size:90%">[[Index|back]]</span></br> | ||
---- | ---- | ||
Latest revision as of 15:48, 20 November 2024
| Pam-malarial LDH and Pan-malarial aldolase
Background: Use of pan-malarial antibodies in RDT tests Use in malaria testing |